Oncology Journal Articles

• Antibiotics Affect Activity of Immune Checkpoint Inhibitors Does the altering of gut microbiota by antibiotics reduce the efficacy of immune checkpoint inhibitors?
  Annals of Oncology, July 2018
• Local Therapy in Patients at High Risk to Die of Metastases When considering local therapy for patients with cancer, treatment risk must be balanced with uncertain benefit.
  Journal of Oncology Practice, July 2018
• Stringent Vaccination of Cancer Patients: Is It Important? New recommendations provide guidance for immunization of cancer patients and survivors.
  Annals of Oncology, July 2018
• Curing More Prostate Cancer: Thinking Through the Options Clinical trials in prostate cancer often take years or decades to yield results. Can time to results be lessened?
  Journal of Clinical Oncology, July 2018
• Adjuvant Chemotherapy for ER+ Breast Cancer Genomic assays and targeted therapies are helping to reduce the use of chemotherapy.
  Journal of the National Cancer Institute, July 2018
• Associations With Mammographic Density in the WECARE Study After diagnosis of breast cancer, should mammographic density be monitored for risk of contralateral breast cancer?
  Breast Cancer Research, July 2018
• Latest Evidence for Particle Therapy in NSCLC What is the latest evidence on proton therapy for locally advanced lung cancer?
  Translational Lung Cancer Research, June 2018
• Oncologists' Recommendations for Early-Stage Breast Cancer Are oncologists recommending less chemotherapy for early breast cancer?
  Journal of the National Cancer Institute, June 2018
• Reducing Unplanned Acute Care for Patients With Cancer Early use of palliative care and identification of patients at risk are strategies that may reduce acute care in patients with cancer.
  Journal of Oncology Practice, June 2018
• Time Is Up for PD-L1 Testing Standardization in Lung Cancer Rapid efforts are needed to determine analytical concordance between PD-L1 assays.
  Annals of Oncology, June 2018
• First-Line Treatment of Hormone-Sensitive Metastatic PCa In addition to standard ADT, which patients with hormone-sensitive metastatic prostate cancer should receive abiraterone, docetaxel, both, or neither?
  Journal of Clinical Oncology, June 2018
• Neurocognitive Function in Survivors of Childhood Cancer Chronic conditions as a result of cancer therapy can impact neurocognitive function of childhood cancer survivors.
  Journal of the National Cancer Institute, June 2018
• Implications of BMI With Breast Cancer Tumor Size High BMI may be associated with having a larger tumor at diagnosis of breast cancer and worse prognosis.
  Breast Cancer Research, June 2018
• Prognostic Value of Primary Tumor Side in RAS Wild-Type mCRC In RAS wild-type mCRC, patients with right-sided tumors have a worse prognosis than those with left-sided tumors, and efficacy of treatment is sided as well.
  Annals of Oncology, June 2018
• St Gallen International Conference on Early Breast Cancer The St Gallen International Expert Consensus Conference has issued new treatment recommendations for women with early-stage breast cancer and guidance for clinicians who manage this population.
  Annals of Oncology, May 2018
• Immune-Modifed Response Evaluation Criteria In Solid Tumors Does this modified RECIST criteria better reflect efficacy of cancer immunotherapy for solid tumors?
  Journal of Clinical Oncology, May 2018
• Sexual Function and Preference for Surveillance in PCa Is active surveillance for low-risk prostate cancer preferred in men who strongly want to preserve sexual function?
  Journal of the National Cancer Institute, May 2018
• Combining Proton Beam Therapy and Immunotherapy Are outcomes improved in patients with NSCLC receiving both proton beam therapy and immunotherapy?
  Translational Lung Cancer Research, May 2018
• Use of cfDNA to Predict Treatment Failure in Rectal Cancer Can circulating cell-free DNA facilitate individualized therapy for patients with locally advanced rectal cancer?
  Annals of Oncology, May 2018
• Geriatric Assessment for Older Patients With Cancer Not only can a geriatric assessment evaluate medical, psychosocial, and functional problems in older patients with cancer, it can also predict toxicity and guide interventions.
  Journal of Oncology Practice, May 2018